|
PHIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.234250E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.511600E-01 |
| Normal-vs-Stage2 |
1.193170E-01 |
| Normal-vs-Stage3 |
2.421600E-01 |
| Normal-vs-Stage4 |
1.687770E-01 |
| Stage1-vs-Stage2 |
2.230400E-01 |
| Stage1-vs-Stage3 |
6.201000E-01 |
| Stage1-vs-Stage4 |
5.227600E-01 |
| Stage2-vs-Stage3 |
3.225200E-01 |
| Stage2-vs-Stage4 |
3.394000E-01 |
| Stage3-vs-Stage4 |
9.251200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.952500E-02 |
| Normal-vs-AfricanAmerican |
8.787800E-01 |
| Normal-vs-Asian |
5.810200E-02 |
| Caucasian-vs-AfricanAmerican |
1.151580E-01 |
| Caucasian-vs-Asian |
8.953900E-02 |
| AfricanAmerican-vs-Asian |
7.090200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.596020E-01 |
| Normal-vs-Female |
1.514570E-01 |
| Male-vs-Female |
9.019000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.124600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.130300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.289200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.262400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.409400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.015600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.299200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.538200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.765600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.783040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.314200E-01 |
| Normal-vs-Grade 2 |
3.048400E-02 |
| Normal-vs-Grade 3 |
4.863600E-01 |
| Normal-vs-Grade 4 |
4.630000E-01 |
| Grade 1-vs-Grade 2 |
3.162400E-01 |
| Grade 1-vs-Grade 3 |
8.691600E-01 |
| Grade 1-vs-Grade 4 |
9.947400E-01 |
| Grade 2-vs-Grade 3 |
4.458000E-02 |
| Grade 2-vs-Grade 4 |
2.207200E-01 |
| Grade 3-vs-Grade 4 |
7.770400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.528090E-02 |
| Normal-vs-ccB subtype |
4.229200E-01 |
| ccA subtype-vs-ccB subtype |
6.682200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.218300E-02 |
| Normal-vs-N1 |
5.142600E-01 |
| N0-vs-N1 |
8.221400E-01 |
|
|
